These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 2535108)
21. Isolation of a novel oncogene, NET1, from neuroepithelioma cells by expression cDNA cloning. Chan AM; Takai S; Yamada K; Miki T Oncogene; 1996 Mar; 12(6):1259-66. PubMed ID: 8649828 [TBL] [Abstract][Full Text] [Related]
22. Rearrangement and expression of myeov and hst in NIH/3T3 transfectants: a caveat for the interpretation of DNA transfection analyses. Brecht M; Steenvoorden AC; Luf S; Bartram CR; Janssen JW Oncol Rep; 2007 May; 17(5):1127-31. PubMed ID: 17390055 [TBL] [Abstract][Full Text] [Related]
23. [Studies on hst, a transforming gene which belongs to a new superfamily of growth factors]. Yoshida T; Sakamoto H; Miyagawa K; Odagiri H; Terada M Hum Cell; 1988 Mar; 1(1):10-6. PubMed ID: 3154010 [TBL] [Abstract][Full Text] [Related]
24. Chromosomal localization of the hst oncogene and its co-amplification with the int.2 oncogene in a human melanoma. Adelaide J; Mattei MG; Marics I; Raybaud F; Planche J; De Lapeyriere O; Birnbaum D Oncogene; 1988 Apr; 2(4):413-6. PubMed ID: 3283658 [TBL] [Abstract][Full Text] [Related]
25. Transformation by basic fibroblast growth factor requires high levels of expression: comparison with transformation by hst/K-fgf. Quarto N; Talarico D; Sommer A; Florkiewicz R; Basilico C; Rifkin DB Oncogene Res; 1989; 5(2):101-10. PubMed ID: 2608276 [TBL] [Abstract][Full Text] [Related]
26. High frequency of mas oncogene activation detected in the NIH3T3 tumorigenicity assay. van 't Veer LJ; van den Berg-Bakker LA; Hermens RP; Deprez RL; Schrier PI Oncogene Res; 1988; 3(3):247-54. PubMed ID: 3060802 [TBL] [Abstract][Full Text] [Related]
27. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829 [TBL] [Abstract][Full Text] [Related]
28. A transforming gene, hst, found in NIH 3T3 cells transformed with DNA from three stomach cancers and a colon cancer. Koda T; Sasaki A; Matsushima S; Kakinuma M Jpn J Cancer Res; 1987 Apr; 78(4):325-8. PubMed ID: 3108211 [TBL] [Abstract][Full Text] [Related]
29. BCL-1 participates in the 11q13 amplification found in breast cancer. Theillet C; Adnane J; Szepetowski P; Simon MP; Jeanteur P; Birnbaum D; Gaudray P Oncogene; 1990 Jan; 5(1):147-9. PubMed ID: 2181375 [TBL] [Abstract][Full Text] [Related]
30. Human oncogenes detected by a defined medium culture assay. Zhan X; Culpepper A; Reddy M; Loveless J; Goldfarb M Oncogene; 1987; 1(4):369-76. PubMed ID: 3330780 [TBL] [Abstract][Full Text] [Related]
31. Identification and expression of human c-Ha-ras and c-sis sequences in NIH3T3 transformants. Weismanová E; Sabová L Neoplasma; 1990; 37(6):675-85. PubMed ID: 2274086 [TBL] [Abstract][Full Text] [Related]
32. Overexpression of the AML1 proto-oncoprotein in NIH3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies. Kurokawa M; Tanaka T; Tanaka K; Ogawa S; Mitani K; Yazaki Y; Hirai H Oncogene; 1996 Feb; 12(4):883-92. PubMed ID: 8632911 [TBL] [Abstract][Full Text] [Related]
33. Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma. Kitagawa Y; Ueda M; Ando N; Shinozawa Y; Shimizu N; Abe O Cancer Res; 1991 Mar; 51(5):1504-8. PubMed ID: 1997190 [TBL] [Abstract][Full Text] [Related]
34. The int-2 gene product acts as a growth factor and substitutes for basic fibroblast growth factor in promoting the differentiation of a normal mouse mammary epithelial cell line. Venesio T; Taverna D; Hynes NE; Deed R; MacAllan D; Ciardiello F; Valverius EM; Salomon DS; Callahan R; Merlo G Cell Growth Differ; 1992 Jan; 3(1):63-71. PubMed ID: 1376141 [TBL] [Abstract][Full Text] [Related]
35. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Lammie GA; Fantl V; Smith R; Schuuring E; Brookes S; Michalides R; Dickson C; Arnold A; Peters G Oncogene; 1991 Mar; 6(3):439-44. PubMed ID: 2011398 [TBL] [Abstract][Full Text] [Related]
36. Detection of transforming genes by transfection of DNA from primary soft-tissue tumours. Gill S; Stratton MR; Patterson H; Spurr NK; Fisher C; Gusterson BA; Cooper CS Oncogene; 1991 Sep; 6(9):1651-6. PubMed ID: 1923531 [TBL] [Abstract][Full Text] [Related]
37. Identification of transforming genes as hst in DNA samples from two human hepatocellular carcinomas. Nakagama H; Ohnishi S; Imawari M; Hirai H; Takaku F; Sakamoto H; Terada M; Nagao M; Sugimura T Jpn J Cancer Res; 1987 Jul; 78(7):651-4. PubMed ID: 3040649 [TBL] [Abstract][Full Text] [Related]
38. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Heaney AP; Horwitz GA; Wang Z; Singson R; Melmed S Nat Med; 1999 Nov; 5(11):1317-21. PubMed ID: 10546001 [TBL] [Abstract][Full Text] [Related]
39. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule. Albor A; Thraves PJ; Dritschilo A; Notario V Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522 [TBL] [Abstract][Full Text] [Related]
40. Transforming genes in human hepatomas detected by a tumorigenicity assay. Yuasa Y; Sudo K Jpn J Cancer Res; 1987 Oct; 78(10):1036-40. PubMed ID: 2824415 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]